UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1463217
IRVING, TX
Position in REGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,653,004
-$618,557 QoQ
Shares Held
2,651
-9.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#553
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $15,880,894 across 17 Biotechnology names. REGN ranks #2 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,438 | $6,178,327 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,651 | $1,653,004 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,155 | $1,250,779 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
13,677 | $1,070,498 | |
| 5 | MRNA |
Moderna, Inc.
|
13,077 | $915,782 | |
| 6 | CBUS |
Cibus, Inc.
|
576,043 | $789,178 | |
| 7 | INCY |
Incyte Corp
|
6,876 | $779,463 | |
| 8 | IMMX |
Immix Biopharma, Inc.
|
70,682 | $728,731 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,653,004 | 2,651 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $2,271,561 | 2,940 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,301,716 | 2,982 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,445,596 | 2,571 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,172,850 | 2,234 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,494,245 | 2,356 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,688,222 | 2,370 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,154,771 | 3,001 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,181,467 | 3,027 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,882,657 | 2,995 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,925,583 | 3,331 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,651,473 | 4,437 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,354,863 | 4,669 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,775,573 | 4,595 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $2,695,486 | 3,736 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $1,074,637 | 1,560 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $891,424 | 1,508 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,087,439 | 1,557 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,028,746 | 1,629 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,037,883 | 1,715 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,078,540 | 1,931 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,094,845 | 2,314 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,145,936 | 2,372 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $1,170,499 | 2,091 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,265,385 | 2,029 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $585,948 | 1,200 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||